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a b s t r a c t
The oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) is a potent transactivator of viral
and cellular transcription. Here, we identiﬁed ELL2 as the sole transcription elongation factor to be
speciﬁcally upregulated in HTLV-1-/Tax-transformed T-cells. Tax contributes to regulation of ELL2, since
transient transfection of Tax increases ELL2 mRNA, Tax transactivates the ELL2 promoter, and repression
of Tax results in decrease of ELL2 in transformed T-lymphocytes. However, we also measured
upregulation of ELL2 in HTLV-1-transformed cells exhibiting undetectable amounts of Tax, suggesting
that ELL2 can still be maintained independent of continuous Tax expression. We further show that Tax
and ELL2 synergistically activate the HTLV-1 promoter, indicating that ELL2 cooperates with Tax in viral
transactivation. This is supported by our ﬁndings that Tax and ELL2 accumulate in nuclear fractions and
that they co-precipitate upon co-expression in transiently-transfected cells. Thus, upregulation of ELL2
could contribute to HTLV-1 gene regulation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human T-cell leukemia virus type 1 (HTLV-1), a delta retro-
virus, is the causative agent of adult T-cell leukemia/lymphoma
(ATL) and of the neurodegenerative disorder HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP) (Poiesz
et al., 1980; Yoshida et al., 1982; Gessain et al., 1985; Osame et
al., 1986). ATL is a severe neoplasia of CD4þ T lymphocytes, which
develops in about 2–5% of infected carriers after lifelong persis-
tence of the integrated provirus. Since ATL therapy remains largely
unsatisfactory till now, break-out of ATL often results in death of
patients (Currer et al., 2012; Matsuoka and Jeang, 2007).
The oncoprotein Tax of HTLV-1 is a potent transactivator of both
cellular and viral transcription. Tax plays an important role in
initiating transformation of T-cells in infected patients and pro-
motes proliferation of infected T-cell clones. Functionally, Tax
interacts with a variety of cellular proteins, thereby fostering an
accumulation of genetic alterations potentially culminating in the
outgrowth of ATL (Boxus et al., 2008). Tax deregulates different
signaling pathways including NF-κB, cAMP response element
binding (CREB), serum response factor, and PI3K/Akt (reviewed
by (Currer et al., 2012; Matsuoka and Jeang, 2007; Hall and Fujii,
2005; Chan and Greene, 2012)). In addition to its interference with
cellular proteins, Tax acts as a potent transactivator of viral
transcription by interacting with and recruiting different tran-
scription factors and histone-modifying enzymes like CREB, CREB
binding protein (CBP), p300, and PCAF to Tax responsive elements
(TRE) within the U3R region of the long terminal repeats (LTR) of
the HTLV-1 provirus (reviewed in (Currer et al., 2012; Boxus et al.,
2008; Nyborg et al., 2010)). The TREs are three conserved 21-bp
repetitive elements called viral cAMP response elements (vCREs)
which are required for Tax–pCREB complex formation (Nyborg
et al., 2010). Furthermore, the positive transcription elongation
factor b, P-TEFb, is recruited to the LTR by Tax (Zhou et al., 2006).
P-TEFb is composed of cyclin-dependent kinase 9 (CDK9) and
cyclin T1, T2 or K, and functions by phosphorylating the C-terminal
domain of the largest subunit of RNA Polymerase II (RNA Pol II)
and negative elongation factors DSIF and NELF. These events
antagonize the actions of the negative factors, release RNA Pol II
from promoter-proximal pausing, and trigger the production of
full-length mRNA transcripts (Barboric and Peterlin, 2005; Peterlin
and Price, 2006). P-TEFb is essential for efﬁcient transactivation of
the HTLV-1-LTR (Zhou et al., 2006; Cho et al., 2007).
Transcription elongation is a key step in gene regulation and
frequently deregulated during the progression of cancer (Luo et al.,
2012). Not only transcription initiation, but also transcription
elongation is important for efﬁcient gene regulation(Peterlin and
Price 2006; Luo et al., 2012). Transcription elongation is regulated
by a variety of speciﬁc classes of transcription elongation factors
that inﬂuence different classes of genes (Sims et al., 2004). Among
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all known elongation factors, ELL2 is the stoichiometrically limit-
ing component of a super elongation complex (SEC), which also
contains P-TEFb, and has been identiﬁed in mixed-lineage leuke-
mia (MLL), during HIV-transcription, and in embryonic stem cells
(Luo et al., 2012; Lin et al., 2010; He et al., 2010; Sobhian et al.,
2010; Lin et al., 2011). ELL2 is a member of the eleven nineteen
rich-leukemia family of elongation factors (ELL family) (Shilatifard
et al., 1997). Functionally, ELL2 keeps the 3'OH end of the nascent
mRNA in alignment with the catalytically active center of RNA Pol
II (Sims et al., 2004; He et al., 2010; Shilatifard et al., 1997). Thus,
ELL2 is important for transition of RNA Pol II from its promoter-
proximal paused state into its elongation state. Moreover, ELL2 had
also been described to regulate pre-mRNA processing and poly-
adenylation of nascent mRNAs during plasma cell differentiation
(Martincic et al., 2009; Milcarek et al., 2011; Benson et al., 2012).
Despite signiﬁcant efforts in the molecular characterization of
the viral Tax oncoprotein, the mechanisms of gene regulation
driving HTLV-1-transcription remain to be fully elucidated (Currer
et al., 2012). In this study, we asked whether HTLV-1 deregulates
the expression of transcription elongation factors. Here, we
identify ELL2 as the sole cellular transcription elongation factor
to be speciﬁcally upregulated in the presence of the viral onco-
protein Tax. We demonstrate that Tax contributes to the main-
tenance of ELL2 in Tax-transformed cells. However, we also show
that ELL2 is still maintained in HTLV-1-infected T-cells that had
lost Tax expression. Finally, we provide evidence that Tax and ELL2
synergistically activate the HTLV-1-promoter and that they are
part of a common complex, indicating that upregulation of ELL2 in
HTLV-1-infected cells is a novel mechanism to modulate viral gene
regulation.
Results
Micro array analysis identiﬁes upregulation of the transcription
elongation factor ELL2 in HTLV-1-/Tax-transformed T-cells
To clarify whether HTLV-1/Tax could perturb components of
the transcriptional elongation machinery, transcriptome analyses
were performed comparing HTLV-1-transformed cells (MT-2) and
ATL-derived cells (StEd) with primary CD4þ T-lymphocytes (Kress
et al., 2010). In addition, Tax-transformed Tesi cells were compared
to Tesi/Tet cells, where Tax expression was repressed (Pichler et al.,
2008). To show the integrity of the micro array, expression levels
of the known Tax-target gene OX40L (gp34, TNFSF4) are displayed
(Miura et al., 1991; Ohtani et al., 1998), which are highly upregu-
lated in Tax-expressing MT-2, Tesi and StEd cells (Table 1). In a
systematic search for classical, positive transcription elongation
factors based on Sims et al. (2004), we found that the expression
pattern of most elongation factors was not changed signiﬁcantly in
the presence of HTLV-1/Tax (Table 1). However, we identiﬁed
signiﬁcant upregulation of a single transcription elongation factor,
the ELL-family member ELL2. Depending on the probe set used in
the microarray, upregulation of ELL2 was between 2-and 11-fold.
Therefore, we conclude that among all currently known positive
transcription elongation factors, only ELL2 is signiﬁcantly upregu-
lated in the presence of HTLV-1/Tax.
ELL2 mRNA and protein are speciﬁcally and signiﬁcantly upregulated
in HTLV-1-infected T-cell lines
To test whether ELL2 expression is a common phenotype of
HTLV-1 infection, quantitative PCR (qPCR; Fig. 1A B) was per-
formed comparing ELL2 copy numbers in HTLV-1-infected
T-cell lines and uninfected controls. ELL2 transcripts were present
in all Tax-expressing HTLV-1-infected T-cell lines including
in vitro-transformed cell lines, ATL-and HAM/TSP-derived cells,
and solely Tax-transformed T-cells (Fig. 1A). The amount of ELL2
transcripts is signiﬁcantly increased (po0.05) in HTLV-1/Tax-
positive cells compared to uninfected controls including cell lines
derived from acute lymphoblastic leukemia, unstimulated PBMC
and primary CD4þ T-lymphocytes (Fig. 1B). Beyond that, ELL2
protein expression was detectable in all HTLV-1/Tax-positive cell
lines as reﬂected by detection of a ca. 80 kDa band of ELL2 protein
species by immunoblotting (Fig. 1C). Tax expression was validated
by qPCR in all HTLV-1/Tax-positive T-cell lines (Supplementary
Fig. 1A), whereas Tax protein could only be detected in 9 of the 14
infected cell lines tested (Supplementary Fig. 1B). Although the
amounts of ELL2 and Tax transcripts moderately correlated in Tax-
expressing T-cell lines (Fig. 1A, Supplementary Fig. 1A; R2¼0.545,
po0.05, N¼14), we did not observe a correlation between the
amounts of ELL2 and Tax protein (Fig. 1C, Supplementary Fig. 1B).
In summary, the transcription elongation factor ELL2 is speciﬁcally
upregulated in HTLV-1-infected Tax-expressing T-cells indepen-
dent of their origin on transcript and protein level.
ELL2 is not upregulated upon mitogenic stimulation of PBMC
HTLV-1-Tax-transformed cell lines express several adhesion
molecules, growth-promoting chemokine receptors, and costimu-
latory receptors on their surface (Kress et al., 2011). Therefore, the
cells accumulate in syncytia and are characterized by high prolif-
eration rates (Matsuoka and Jeang, 2007; Popovic et al., 1983).
To test whether upregulation of ELL2 is a consequence of T-cell
proliferation only, PBMC were cultured in the presence of mitogenic
stimulation (PHA-P, IL-2) and samples for isolation of RNA and
protein were taken at different time points post stimulation.
Detection of transcripts of the costimulatory tumor necrosis super-
family receptor 4-1BB served as a control for mitogenic stimulation.
Transcripts of 4-1BB were only slightly expressed in unstimulated
PBMC, but increased following stimulation (Supplementary Fig. 2A).
Despite efﬁcient mitogenic stimulation, we could neither observe
an increase of ELL2 transcripts (Supplementary Fig. 2B) nor of ELL2
protein (Supplementary Fig. 2C). 293 T cells transfected with an
ELL2 expression plasmid served as a positive control for ELL2
protein expression. Collectively, these data indicate that ELL2 is
not upregulated by mitogen signals.
Transient expression of Tax leads to induction of ELL2 mRNA
The expression pattern of ELL2 in HTLV-1-infected cells led us
to ask, whether Tax alone is sufﬁcient for induction of ELL2 gene
expression. Therefore, transient transfections of 293 T cells were
performed. Measuring Tax and ELL2 transcripts by qPCR revealed
that overexpression of increasing amounts of Tax led to a dose-
dependent increase of ELL2 transcripts, which correlates with Tax
transcripts (Fig. 2A; R²¼0.8991, po0.01). Despite high copy
numbers of Tax, only low copy numbers of induced endogenous
ELL2 could be measured upon transfection of Tax expression
plasmids. Although ELL2 copy numbers were in the range of those
of HTLV-1-transformed cells (Fig. 1A), we did not observe any
changes in the amount of endogenous ELL2 protein after Tax
expression independent of the amount of Tax protein expressed
(Fig. 2B). Taking into consideration that ELL2 is post-translationally
modiﬁed by ubiquitination and has a short half-life (Liu et al.,
2012), we tested whether proteasome inhibition using MG-132
results in an accumulation of ELL2 protein upon expression of Tax.
We observed an overall accumulation of ubiquitinated proteins
(Fig. 2C), however, an increase of endogenous ELL2 protein was not
detectable in the presence of Tax, possibly due to missing cofactors
required for ELL2 protein stability (Liu et al., 2012). Endogenous
ELL2 was also not inducible upon transient expression of Tax in
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Table 1
Transcriptional expression of elongation factors in HTLV-1-/Tax-transformed T-cells.
Gene Average signalsa Fold changeb probe set
Tax-positive Tax-negative
StEd MT-2 Tesi Tesi/Tet CD4þ Tesi vs
Tesi/Tet
P value StEd vs
CD4þ
P value MT-2 vs
CD4þ
P value
ELL family ELL3 16 17 29 19 25 2 0.22 1 0.15 1 0.05 219,517_at
ELL2 858 310 1025 328 81 3 o 0.01 11 0.02 4 0.06 226,982_at
ELL2 647 708 426 140 92 3 0.04 7 o0.01 8 o0.01 214,446_at
ELL2 1836 1945 1926 841 242 2 0.06 8 o0.01 8 o0.01 226,099_at
ELL 64 59 48 51 64 1 0.77 1 0.98 1 0.74 204,096_s_at
SII class TCEA1 1631 2223 2570 3393 1775 1 0.40 1 0.46 1 0.22 216,241_s_at
TCEA2 199 86 286 380 150 1 0.49 1 0.01 1 o0.01 203,919_at
TCEAL8 344 337 472 510 296 1 0.16 1 0.93 1 0.94 224,819_at
SIII class TCEB1 1582 1403 1880 1749 1567 1 0.49 1 0.12 1 0.03 202,824_s_at
TCEB1 189 147 310 253 191 1 0.23 1 0.16 1 0.11 202,823_at
TCEB2 2089 2574 2219 2172 1990 1 0.14 1 0.17 1 0.08 200,085_s_at
TCEB3 193 223 138 133 189 1 0.14 1 0.37 1 0.67 202,819_s_at
TCEB3 105 131 86 99 115 1 0.78 1 0.46 1 0.85 202,818_s_at
P-TEFb CDK9 168 148 92 58 203 2 0.08 1 0.17 1 0.04 203,198_at
Additional SSRP1 747 1107 412 329 755 1 0.23 1 0.86 1 0.02 200,956_s_at
Elongation SSRP1 748 1061 490 335 823 1 0.07 1 0.24 1 0.03 200,957_s_at
Factors IWS1 335 447 398 288 378 1 0.07 1 0.11 1 0.04 224,768_at
Control TNFSF4 307 1389 512 24 49 22 o0.01 6 o0.01 29 o0.01 207,426_s_at
a Average ﬂuorescence intensities were rounded to integers.
b Values depicting the fold change of expression were rounded to integers, P values were rounded on two decimals.
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Fig. 1. ELL2 is signiﬁcantly upregulated in HTLV-1/Tax-transformed cells. (A, B) Quantitative PCR (qPCR) of ELL2 transcripts normalized to ßActin in HTLV-1/Tax-positive T-cell
lines derived from in vitro transformation (ivt), Tax-transformation (Tax), ATL or HAM/TSP patients, and in HTLV-1/Tax negative T-cell lines derived from acute lymphoblastic
leukemia (ALL). Mean values 7 standard errors (SE) are shown (n¼3; po0.5; t-test). rcn, relative copy number. In (B), peripheral blood mononuclear cells (PBMC) and
isolated CD4þ T-cells from uninfected patients were analyzed in addition to the cell lines depicted in (A). (C) Whole cell extracts of HTLV-1/Tax-positive and HTLV-1/Tax-
negative T-cells were analyzed by western blotting with the indicated antibodies. Shown are results from one of three independently performed experiments with similar
results. ctrl indicates control. ELL2 and αTubulin were quantitated by densitometry and normalized values are shown.
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Fig. 2. Tax transcriptionally induces ELL2 (A and B). 293 T cells were transfected with increasing amounts of pcTax expression plasmids (0, 0.5, 1.0, 1.5, 2.0 mg) replenished
with pcDNA3. 1 (mock) to 2 mg using Lipofectamine. In addition, untransfected cells (UT) were analyzed. (A) Detection of Tax and ELL2 normalized on ßActin by qPCR and
correlation of Tax and ELL2 transcripts using Pearson's correlation (R2¼ 0.8991; po0.01) (B) 293 T cells were lysed for western blotting. Detection of ELL2, Tax and ßActin is
shown. Co-expression of pCMV-ELL2 and pcTax served as positive control. Shown are results from one of three independently performed experiments with similar results.
Tax and ßActin were quantitated by densitometry. Normalized values of cells transfected with 0.5 mg of pcTax were set as 1. (C) 293 T cells were transfected with 1.5 mg pcTax
or mock using GeneJuice. Cells were incubated in the presence of the proteasome inhibitor MG-132 (10 mM, 4 h) or the solvent control DMSO. Immunoblots show detection of
ELL2, Tax and αTubulin. Cellular ubiquitination (panUbi) was detected to verify MG-132 efﬁcacy. Lysates from 293 T cells expressing Tax and ELL2 served as positive control.
(D and E) 293 T cells were transfected with increasing amounts of pcDNA3.1-HBZ-wt-Myc/his expression plasmids (0, 0.5, 1.5 mg) replenished with pcDNA3.1 (mock) to 2 mg.
(D) Detection of ELL2 normalized on ßActin by qPCR. Mean values 7SE of three independent experiments are shown. (E) 293 T cells were lysed for western blotting.
Detection of ELL2, HBZ (myc) and αTubulin is shown. Lysates from 293 T cells expressing pEF1α-ELL2 served as positive control. Shown are results from one of three
independently performed experiments with similar results. (F) Scheme of the ELL2 promoter. Putative NF-κB and CRE-sites are indicated. þ1 indicates the transcription start
site, Δ, antisense TRE-site. Luciferase activities were measured in 293 T cells after transfection of a luciferase reporter construct of the human ELL2 promoter (0.3 mg ELL2-G-
Luc) and 0.8 mg of expression constructs for Tax, the respective Tax mutants, or a control (pEF1α, mock). Three independently transfected samples were lysed 48 h after
transfection and luciferase activities were normalized on protein content of the respective sample (RLU/protein). Mean values of the fold change 7SE are shown and were
compared using a t-test (n¼3). * indicates po0.05. ns, not signiﬁcant.
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Jurkat T-cells which may be explained by the much lower expres-
sion levels of Tax in Jurkat cells (copy numbers in the range of 1;
Supplementary Fig. 3) compared to 293 T cells (copy numbers in
the range of 10102; Fig. 2A). To analyze whether other viral
proteins than Tax are capable to induce ELL2, 293 T cells were
transfected with two different concentrations of expression plas-
mids encoding HBZ. Despite detectable expression of HBZ, neither
ELL2 mRNA (Fig. 2D) nor ELL2 protein (Fig. 2E) was inducible by
HBZ. In conclusion, these data show that transient expression of
Tax is sufﬁcient for induction of ELL2 transcripts if expressed at
high levels only, however, not for induction of ELL2 protein.
Thus far, the ELL2 promoter has not been studied and char-
acterized at all. Bioinformatics analysis revealed that the putative
ELL2 promoter (nucleotides -1142 to þ154) harbors several
putative NF-κB binding sites and cyclic AMP response elements
(CRE; Fig. 2F). The CRE element located downstream of the
transcription start site resembles a TRE site on the antisense
strand. To test whether transcriptional induction of ELL2 by Tax
depends on activation of the ELL2 promoter, luciferase assays were
performed using a reporter construct expressing the gaussia
luciferase gene under control of the putative ELL2 promoter
(nucleotides 1142 to þ154). Luciferase activity determined from
transfected 293 T cells revealed that Tax signiﬁcantly transacti-
vates the ELL2 promoter ELL2-GLuc (Fig. 2 F; po0.01; t-test). In
accordance with the low concentrations of ELL2 mRNA in 293 T
cells, basal activity of ELL2-GLuc was negligible low (not shown).
To clarify which Tax-induced signalling pathways are required
for transcriptional induction of ELL2, transactivation of the ELL2-
promoter was tested upon co-transfection of expression constructs
for an NF-κB-deﬁcient Tax mutant (M22), a CREB-deﬁcient mutant
(M47), or a mutant exhibiting deﬁciencies for both NF-κB and
CREB signalling (M7). None of the mutants tested transactivated
the ELL2-promoter compared to Tax wildtype. These data show
that Tax-mediated activation of the ELL2 promoter requires both
NF-κB and CREB signals suggesting that Tax-mediated transactiva-
tion of the ELL2 promoter occurs indirectly through these tran-
scription factors. Taken together, we found that Tax dose-
dependently induces ELL2 transcripts. Tax-mediated induction of
ELL2 depends on promoter transactivation. However, the ubiqui-
tous expression of ELL2 protein in Tax-transformed, but not in
transiently Tax-expressing cells led us to the conclusion that, in
the latter, cofactors are missing which are required for induction
or stability of ELL2 protein.
Tax contributes to maintenance of ELL2 in Tax-transformed T cells
To further clarify whether Tax is required for ELL2 expression,
transient Tax knockdown experiments in chronically infected
HTLV-1-transformed MT-2 cells were performed. Use of siRNAs
targeting Tax or unspeciﬁc control siRNAs (siNon) revealed that an
efﬁcient knockdown of Tax led to a moderate reduction of ELL2
protein over time (Fig. 3A). Quantitation by densitometry revealed
reduction of ELL2 to 70% in the presence of siTax compared to
control cells (siNon, 100%). Due to high Tax expression levels and
the existence of several proviruses within MT-2 (Kobayashi et al.,
1984), we switched to the solely Tax-transformed Tesi cells, which
allow a more robust repression of Tax expression (Schmitt et al.,
1998). After repression of Tax to undetectable copy numbers
(Tesi/Tet), a signiﬁcant decrease of both ELL2 transcripts (Fig. 3B;
po0.05) and protein (Fig. 3C) was detectable, conﬁrming observa-
tions obtained in microarrays (Table 1). However, despite the
absence of Tax, ELL2 was still detectable (Fig. 3B and C), suggesting
that expression of ELL2 can still be maintained at low levels in
transformed lymphocytes after reduction or loss of Tax. To exclude
that reduction of ELL2 might be affected by growth-arrest of Tesi
cells upon repression of Tax (Schmitt et al., 1998), Tesi cells were
cultured under serum deprivation (20%, 10%, 5%, 0% FCS) for 48 h.
Although serum-starved Tesi cells ceased to divide at low serum
concentrations as detected by ﬂow cytometry (Fig. 3F, 0% FCS), the
expression levels of ELL2 and Tax protein (Fig. 3D) and transcripts
(Fig. 3E) were not affected. Altogether, these data indicate that
Tax contributes to the maintenance of ELL2 mRNA and protein in
Tax-transformed cells.
ELL2 is upregulated in HTLV-1-transformed T cells and freshly-
isolated PBMCs from HTLV-1-infected patients independent of
continuous Tax expression
Given that Tax is not expressed in more than 50% of ATL cases
due to deletions of the 50-LTR, DNA hypermethylation or mutations
(Matsuoka and Jeang, 2007; Furukawa et al., 2001; Koiwa
et al., 2002; Takeda et al., 2004; Cheng et al., 2012), and that
ELL2 is still present despite repression of Tax to undetectable
levels in Tesi/Tet cells (Fig. 3B and C), we asked whether ELL2 may
also be present in HTLV-1-transformed cells that are Tax-negative.
For this purpose, the ATL-derived cell line TLOM1 (TL-om1)
(Sugamura et al., 1984) was compared to Tax-transformed Tesi
cells (Fig. 4A and B). Despite undetectable levels of Tax conﬁrming
earlier observations (Hironaka et al., 2004), both ELL2 transcripts
and protein could be detected in TLOM1 cells. HTLV-1-infection of
TLOM1 was veriﬁed by RT-PCR of the pol gene (data not shown).
Thus, ELL2 can be maintained in chronically-infected T cells
independent of continuous Tax expression.
Next, we asked whether upregulation of ELL2 is also a common
phenotype of freshly isolated cells from HTLV-1-infected patients.
For this purpose, PBMC were isolated from blood samples of three
anonymized HTLV-1-infected patients and from three uninfected
controls. After diagnosis of HTLV-1-infection and measurement of
the proviral load by qPCR (Fig. 4D), isolated PBMC were kept in
short term culture in the presence of mitogenic stimuli including
phytohemagglutinin (PHA-P; 2 mg/ml) and interleukin 2 (IL-2;
50 U/ml). After one week of cell expansion, RNA was isolated
and subjected to cDNA synthesis followed by qPCR. In comparison
to similarly-cultured controls from uninfected PBMC, the amount
of ELL2 transcripts was signiﬁcantly upregulated in ex vivo PBMC
from HTLV-1-infected patients (Fig. 4C; po0.05; t-test). Tax
expression could not be detected by qPCR in all three infected
patients tested (data not shown). Taken together, ELL2 upregula-
tion is a common phenotype of HTLV-1-infected cells including
primary cells derived from infected patients independent of
continuous Tax expression.
ELL2 enhances Tax-mediated transactivation of the HTLV-1-promoter
and of a CRE-reporter, but not of an NF-κB-dependent reporter
ELL2 is the stoichiometrically limiting component of the
transcription elongation machinery during HIV-transcription (He
et al., 2010; Liu et al., 2012), however, the inﬂuence of ELL2 on
HTLV-1 gene expression has not been investigated. Owing to our
ﬁndings showing Tax-dependent upregulation of ELL2 in Tax-
expressing cells and strong expression of ELL2 in HTLV-1-
infected cells, we tested the hypothesis that ELL2 inﬂuences Tax-
mediated transactivation of the HTLV-1 promoter. Therefore,
luciferase assays were performed using the HTLV-1 U3R promoter
as a reporter (Fig. 5A) and expression constructs for both Tax and
ELL2 under control of the NF-κB-independent EF1α-promoter.
Conversely to Tax, which is a potent inducer of the HTLV-1-
promoter (Felber et al., 1985) and led to 195-fold activation, ELL2
alone could not transactivate the promoter. Interestingly, co-
expression of Tax and increasing amounts of ELL2 led to a
signiﬁcant and dose-dependent increase of promoter transactiva-
tion ranging from 377- to 533-fold (t-test; n¼4; po0.01), thus,
M.C. Mann et al. / Virology 464-465 (2014) 98–110102
demonstrating a strong synergistic effect of Tax and ELL2 on the
viral U3R.
Due to the fact that Tax-pCREB complexes not only interact
with viral CRE sites, but also with CRE-containing promoter
regions of cellular genes (Nyborg et al., 2010; Kim et al., 2010),
we asked whether ELL2 also affects Tax-mediated transactivation
of cellular CREs. For this purpose, luciferase assays under the same
conditions as in Fig. 5A were performed using a CRE-dependent
reporter plasmid (Fig. 5B). Tax mediated transactivation of the
CRE-reporter (4-fold activation) could be enhanced signiﬁcantly
but not dose-dependently by co-expression of ELL2 (12-fold).
However, overall transactivation rates were lower than those
observed when using the HTLV-U3R. Nevertheless, ELL2 enhances
Tax-mediated transactivation of a cellular CRE-containing reporter
gene.
To test whether ELL2 also inﬂuences Tax-mediated activation of
other cellular signaling pathways, luciferase assays were per-
formed using an NF-κB-dependent reporter plasmid (Fig. 5C).
Tax is a potent inducer of NF-κB signaling and activates the
pathway by physical interaction with the IKKγ subunit of the IKK
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complex in the cytoplasm (Qu and Xiao 2011). The IKK complex
leads to phosphorylation of the inhibitory IκBα, which sequesters
p50/p65 (RelA) heterodimers in the cytoplasm. Phosphorylation of
IκBα at serine residues 32 and 36 triggers ubiquitination and
proteasomal degradation of IκBα thereby freeing p50/p65 hetero-
dimers, which translocate to the nucleus and regulate gene
expression (Qu and Xiao, 2011). We conﬁrmed that Tax indeed
activates the NF-κB-dependent reporter (Fig. 5C), whereas co-
expression of a dominant negative inhibitor of IκBα (pIκBα-DN),
which carries S32/36 A mutations (Voll et al., 2000), fully pre-
vented Tax-mediated activation of the reporter. As already shown
for the viral U3R promoter, expression of ELL2 alone could not
activate the NF-κB-dependent reporter (Fig. 5C). Despite slight
oscillations, co-expression of Tax and increasing amounts of ELL2
did not signiﬁcantly promote Tax-mediated activation of the NF-κB
reporter. However, we cannot exclude that activation of the NF-kB
signaling pathway is exhausted at used Tax concentrations. Thus,
ELL2 speciﬁcally enhances Tax-mediated activation of the viral
promoter and of a CRE-reporter, while activation of an NF-κB-
dependent reporter remains largely unaffected in our model system.
While the viral promoter U3R mainly serves as a readout
system for nuclear Tax activities, the NF-κB-dependent reporter
rather reﬂects cytoplasmic Tax activities. To test whether the
subcellular localization of Tax and ELL2 correspond to the mea-
sured reporter activities, nuclear-cytoplasmic fractionation of
transiently-transfected 293 T cells was performed (Fig. 5D). Tax,
which is known to shuttle between the nucleus and the cytoplasm
(Burton et al., 2000), could be detected in both fractions, however,
in the nuclear-enriched fraction, expression levels were higher.
ELL2 predominantly localized to the nuclear-enriched fraction and
only a faint band of ELL2 could be detected in the cytoplasmic-
enriched fraction. Thus, both Tax and ELL2 predominantly localize
to nuclear fractions upon transient expression.
To test whether ELL2 affects transactivation of the viral pro-
moter in HTLV-1-infected T cells, ELL2 was knocked down by
siRNAs in MT-2 cells and reporter activity of the co-transfected
HTLV-1 U3R was measured (Fig. 5E). In comparison to an unspe-
ciﬁc control siRNA (siNon), use of pre-validated siRNAs targeting
ELL2 led to the reduction of ELL2 protein and to 25% reduction of
reporter activity (t-test; n¼3; po0.05). These data suggest that
ELL2 also contributes to LTR-transactivation in chronically-infected
T-cells. Subcellular fractionation revealed that both Tax and ELL2
are present in nuclear-enriched and cytoplasmic-enriched frac-
tions in HTLV-1-infected MT-2 cells, however, the amount of ELL2
was much higher in the nuclear fraction (Fig. 5F).
ELL2 and Tax interact in vivo
To clarify whether ELL2 and Tax are part of the same protein
complex in mammalian cells, co-immunoprecipitations were per-
formed upon overexpression of Tax and ELL2 in 293T cells. Expres-
sion of the respective proteins was controlled by immunoblot of the
input fraction. The lysates were precipitated using speciﬁc anti-
bodies targeting ELL2 or Tax. On the one hand, precipitation of ELL2
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revealed that Tax speciﬁcally co-precipitates with ELL2 (Fig. 6A)
when the two proteins were co-expressed, but not in the absence of
ELL2, conﬁrming a speciﬁc interaction. Precipitations using isotype-
matched control antibodies were used to control the speciﬁcity of
the precipitation. On the other hand, precipitation of Tax showed
speciﬁc co-precipitation of ELL2 (Fig. 6B) upon co-expression of
both proteins. From this we conclude that ELL2 and Tax are part of a
common complex suggesting that ELL2 and Tax interact in vivo.
Collectively, our data demonstrate that the transcription
elongation factor is speciﬁcally upregulated in HTLV-1-infected
T-cells and the viral Tax protein contributes to the regulation
of ELL2 expression. We provide evidence that Tax and ELL2
interact in vivo and synergistically activate Tax-dependent
transcription of the viral promoter suggesting that upregula-
tion of ELL2 by Tax contributes to a novel strategy of viral gene
regulation.
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Discussion
Transcriptional elongation and factors that regulate this pro-
cess are highly essential for proper regulation of gene expression
(Sims et al., 2004) and have been studied intensively in retro-
viruses (HIV) and mixed-lineage leukemia (MLL). We screened for
deregulation of transcriptional elongation factors by the retrovirus
HTLV-1, which causes ATL. Here, we show that ELL2 is the sole
known transcription elongation factor speciﬁcally upregulated in
HTLV-1-transformed cells. The viral Tax oncoprotein contributes to
ELL2 regulation, but continuous Tax expression is not required
for sustaining ELL2 expression in late stages of persistent HTLV-1
infection. Functional data show that ELL2 dose-dependently
enhances Tax-mediated transactivation of the HTLV-1-promoter.
Interestingly, co-immunoprecipitations revealed that Tax and ELL2
are interacting in vivo. Thus, upregulation of ELL2 in HTLV-1-
transformed cells reﬂects a novel possibility to modulate HTLV-1
gene expression.
In this study, we have provided evidence by four approaches
that Tax contributes to regulation of ELL2 expression. (1) Expres-
sion of Tax at high doses induces ELL2 transcripts, but not the
protein. This is in line with observations showing that endogenous
ELL2 is an unstable, short-lived protein (He et al., 2010), and it is
regulated at the level of protein stability (Liu et al., 2012). Despite
efﬁcient chemical inhibition of the proteasome as reﬂected by
an overall increase of cellular ubiquitination, no enrichment of
endogenous ELL2 protein could be detected, contrasting results
from He et al. (2010). In addition, ELL2 protein could not be
detected following Tax expression. We speculate that the amounts
of endogenous ELL2 induced by Tax are either too low to be
detected by immunoblot, or that cofactors required for stability of
endogenous ELL2 are missing in transiently transfected cells, while
they are present in HTLV-1-transformed cells. (2) Sole expression
of Tax leads to transactivation of the human ELL2 promoter.
(3) Repression of Tax in chronically HTLV-1-infected T-cells by
RNA interference leads to a transient decrease of ELL2 protein.
(4) Further studies in Tax-transformed Tesi cells revealed, that
a more robust repression of Tax to undetectable levels leads
to signiﬁcant reduction of both ELL2 transcripts and protein.
Although Tesi cells are growth-arrested upon repression of Tax
(Schmitt et al., 1998), we exclude that reduced proliferation affects
ELL2 expression, since both starvation-induced growth arrest of
Tesi cells and mitogenic stimulation of PBMC did not affect ELL2
expression. This goes in line with data obtained in isolated,
activated CD4þ T-cells (Benson et al., 2012). Collectively, Tax is
necessary for maintaining ELL2 expression in Tax-expressing,
transformed T-cell lines, but is only sufﬁcient for transcriptional
induction of ELL2 if expressed at high concentrations. Use of Tax
mutants shows that both NF-κB and CREB signals are required for
Tax-mediated transactivation of the ELL2 promoter suggesting that
transactivation occurs indirectly through these transcription fac-
tors. However, we cannot exclude that Tax-containing complexes
directly bind onto a CRE or TRE on the ELL2 promoter which may
contribute to regulation of ELL2 expression as it had been shown
earlier for other cellular genes (Kim et al., 2010; Chevalier et al.,
2014). Thus, further studies using Tax as a model system may help
to get further insights into the widely unknown transcriptional
regulation of ELL2.
The elongation stage of transcription and factors regulating this
process could be central for oncogenic transformation and leuke-
mia pathogenesis (Luo et al., 2012; Mueller et al., 2009). Thus far,
deregulation of transcriptional elongation has been described as
an essential step for the development of MLL where ELL is a
frequent translocation partner of the MLL gene (Luo et al., 2012).
Our data demonstrating strong upregulation of the ELL2 protein
in cells derived from virus-induced ATL hint at a novel role
of deregulated elongation factors in other types of leukemia
than translocation-dependent leukemia. ATL cells usually do not
express Tax at signiﬁcant levels due to deletion of the 50 LTR,
hypermethylation of the provirus, or due to genetic alterations of
the Tax gene (Matsuoka and Jeang, 2007; Furukawa et al., 2001;
Koiwa et al., 2002; Takeda et al., 2004; Cheng et al., 2012).
However, our ﬁndings support the notion that ELL2 could also
fulﬁll biological functions in ATL independent of continuous Tax
expression: (1) ELL2 is not completely repressed upon repression
of Tax to undetectable levels in Tesi cells, (2) ELL2 is also present in
an ATL-derived HTLV-1-transformed cell line that is Tax-negative
(TLOM1), and (3) ELL2 is upregulated in Tax-negative PBMC of
HTLV-1-infected donors. These data suggest that in late stages of
HTLV-1-infection, Tax is no longer required to maintain ELL2.
It would be interesting to see whether there is a negative or
positive correlation between ELL2 and the proviral load in a larger
patient group. ELL2 may also be involved in the transformation
process of CD56þ T-cell large granular lymphocyte leukemia
due to its selective upregulation in cells derived from aggressive
phase compared to those derived from the same clone from chronic
phase (Daibata et al., 2004). A proliferation- and leukemia-
promoting effect may also be deduced from ﬁndings in plasma
cells, where ELL2 is speciﬁcally required for pre-mRNA proces-
sing and expression of the survival-promoting receptor BCMA
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(TNFRSF17) (Benson et al., 2012). Our data showing that ELL2 does
not enhance Tax-mediated activation of an NF-κB-dependent
reporter argue against a direct inﬂuence of ELL2 on NF-κB-
dependent cellular gene expression in our model system. However,
we found that Tax-mediated induction of a CRE-reporter was
enhanced by ELL2. Interestingly, recent studies have suggested that
a signiﬁcant number of CRE-containing cellular genes are deregu-
lated by Tax (Nyborg et al., 2010; Kim et al., 2010; Saggioro, 2011).
Thus, we cannot exclude that certain cellular Tax targets and
signaling pathways are affected by ELL2.
We found that the transcription elongation factor ELL2 is a
target of Tax and promotes Tax-mediated transactivation of the
HTLV-1-promoter. Among cellular elongation factors, only the
transcription elongation factor P-TEFb (CDK9/Cyclin T1) has thus
far been implicated in the regulation of HTLV-1 gene expression
(Zhou et al., 2006). In contrast to several cellular host factors that
stimulate Tax-mediated transactivation of the HTLV-1-promoter
(reviewed in (Currer et al., 2012)), transcriptional activity of Tax
can also be suppressed by host factors like the major histocompat-
ibility complex class II transactivator CIITA (Tosi et al., 2011).
Therefore, the relative contribution of ELL2 and other host factors
to HTLV-1 gene expression during HTLV-1 pathogenesis remains to
be determined.
The Tax oncoprotein contains a nuclear localization signal
(Smith and Greene, 1992) and accumulates in transcriptional hot
spots, Tax speckled structures or nuclear bodies (Bex et al., 1997;
Semmes and Jeang, 1996). The formation of Tax nuclear bodies,
which contain RelA/CBP/p300, is implicated in transcriptional
activation (Lamsoul et al., 2005; Nasr et al., 2006), however, recent
data show that Tax nuclear body formation is dispensable for
activation of NF-κB (Bonnet et al., 2012). We demonstrate that
ELL2 enhances Tax-mediated transactivation of the HTLV-1-
promotor. It was tempting to speculate that recruitment of ELL2
into close proximity of Tax in the nucleus enhances HTLV-1
transcription. This idea is supported by our ﬁndings that Tax and
ELL2 predominantly accumulate in nuclear fractions in both
transiently-transfected and chronically infected cells. Moreover,
Tax-mediated activation of an NF-κB reporter, which is also a read
out system for cytoplasmic Tax signals, is not enhanced by ELL2.
Finally, we found that Tax and ELL2 co-precipitate each other
in vivo, indicating that they are part of a common complex.
ELL2 is localized in a super elongation complex (SEC) together
with the elongation factor P-TEFb (Lin et al., 2010; He et al., 2010;
Sobhian et al., 2010). Within the SEC, AFF4 protein serves as a
scaffold and interacts with Cyclin T1, ELL2, and ENL/AF9 (Chou et
al., 2013). The latter targets the complex to RNA Pol II on
chromatin through contacting the human polymerase-associated
factor complex (He et al., 2011), resulting in an active transcription
(Lin et al., 2010). Tax directly interacts with Cyclin T1, and
precipitation of Tax co-precipitates both Cyclin T1 and CDK9 in
infected cells (Zhou et al., 2006; Cho et al., 2007). P-TEFb exists
within HTLV-1-transformed cells in active complexes (free P-TEFb)
and in inactive small nuclear ribonucleoprotein (7SK snRNP)
complexes that can be regulated by Tax expression. Tax, through
interaction with Cyclin T1, can decrease the interaction of 7SK
snRNP and HEXIM1 with P-TEFb, which favors the establishment
of Tax-containing active, low molecular weight complexes and
activates viral transcription (Cho et al., 2010). Our ﬁndings show-
ing a synergistic effect of Tax and ELL2 on HTLV-1-transcription,
but not on an NF-kB-dependent reporter, lead us to speculate that
ELL2 and Tax are part of the active complex containing P-TEFb.
This is further supported by our ﬁndings that at least ELL2 and Tax
are part of a common complex in vivo. Interestingly, a synergistic
effect of ELL2 and the HIV-encoded transactivator Tat on HIV-
transcription had been described (He et al., 2010). Moreover,
knockdown of ELL2 blocked the ability of the HIV inducer JQ1 to
activate HIV transcription (Bartholomeeusen et al., 2012). In
contrast to HIV/Tat, which promotes formation of the SEC and in
turn stabilizes ELL2 (He et al., 2010; Liu et al., 2012), we found that
ELL2 can also be transcriptionally induced by HTLV/Tax, reﬂecting
a novel strategy to regulate ELL2 by human retroviruses. Thus, an
area for future investigations is to determine whether ELL2
functions as a transcription elongation factor and whether it is a
part of a SEC in HTLV-1-transformed cells, and if so, to deﬁne the
relative contributions of ELL2-containing complexes to Tax-/virus-
induced leukemogenesis.
Conclusions
Given its importance in the formation of transcription elonga-
tion complexes, the identiﬁcation of ELL2 as a novel target of
HTLV-1/Tax, its synergism with Tax to foster HTLV-1 promoter
transactivation, and its interaction with Tax in vivo, provides a
route for the development of strategies to modulate viral gene
expression during HTLV-1-pathogenesis. Our studies are the ﬁrst
to implicate the HTLV-1 Tax oncoprotein in the regulation of the
transcription elongation factor ELL2. Remarkably, continuous Tax
expression is not necessarily required for sustained ELL2 expres-
sion in virus-transformed cell.
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Materials and methods
Ethics statement
Peripheral blood mononuclear cells (PBMC) from anonymized
HTLV-1-positive patients were provided by the Diagnostics Section
(Institute of Clinical and Molecular Virology, Erlangen, Germany),
and PBMC from anonymized uninfected controls were obtained
from the Institut für Transfusionsmedizin (Suhl, Germany).
Informed consent was not requested as the data were analyzed
anonymously and the samples had not been collected speciﬁcally
for this study. This procedure was approved by the Ethics Com-
mittee of the Medical Faculty of Friedrich-Alexander-Universität
Erlangen-Nürnberg (Erlangen, Germany).
Cell culture
The different HTLV-1-positive T-cell lines were cultured as
described previously (Kress et al., 2011; Hironaka et al., 2004) and
comprise of cell lines derived from in vitro-transformation (C8166
(C8166-45), C91-PL, MT-2), ATL (HuT-102, ATL-1, Champ, JuanaW,
PaBe, StEd, TL-Om1), or HAM/TSP (Abgho, Eva, Nilu, Xpos). Tesi cells
are primary human T-cells immortalized by an expression cassette
for the Tax protein, which was transduced with a rhadinoviral
vector. Tesi cells feature tetracycline-repressible Tax expression after
culture in medium containing 1 mg/ml tetracycline for 10 days (Tesi/
Tet) (Schmitt et al., 1998). 293 T cells were grown in Dulbecco's
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modiﬁed Eagle medium with 10% fetal calf serum, 1 mg/ml Strep-
tomycin, and 1 mg/ml Penicillin; the HTLV-1-negative, leukemic
T-cell lines Jurkat, CEM, Molt-4 and HuT-78 were grown in culture
medium containing 45% Panserin, 45% RPMI 1640 M, 10% FCS, 1 mg/
ml Glutamin, and 1 mg/ml Gentamycin. PBMC from anonymized
patients were isolated using Ficoll-Hypaque gradient centrifugation
(Biocoll, Biochrom), stimulated with 2 mg phytohemagglutinin
(PHA-P; Sigma) in RPMI 1640 M containing 50 U/ml interleukin-2
(IL-2) and 20% FCS for 24 h and then cultured without PHA-P.
CD4þ T-cells were isolated from PBMC of uninfected patients using
CD4þ T-cell isolation kit II (Miltenyi Biotec). Purity was controlled by
ﬂow cytometry.
Plasmids
pEF1α-ELL2 was cloned from pCMV-ELL2 (Origene; GenBank:
NM_012081.3; in pCMV6-Entry) using BamHI and NotI restriction
enzymes and ligated into pEF1myc-His (Life Technologies). Plas-
mids pEF1α-Tax (in pEFneo) (Shoji et al., 2009), pcTax (Rimsky et
al., 1988), a dominant negative inhibitor of IκBα (pIκBα-DN) (Voll et
al., 2000), the NF-κB-deﬁcient Tax mutant M22, the CREB-deﬁcient
Tax-mutant M47, and the double-deﬁcient Tax mutant M7 have
been described before (Smith and Greene, 1990). The expression
plasmid encoding HBZ (pcDNA3.1-HBZ-wt-Myc/his) has been
described (Thebault et al., 2004). HTLV-1 U3R-Luc (pGL3-U3R) is
derived from pGL3-basic (Promega) containing a ﬁreﬂy luciferase
(Luc) gene under control of the HTLV-1-promoter U3R cloned via
XhoI and HindIII sites. The ELL2 promoter reporter construct (ELL2-
GLuc) carries the Gaussia luciferase gene under control of the
human ELL2 promoter (nucleotides -1142 to þ154; NT_034772;
NM_012081) and was obtained from tebu-bio GmbH. pcDNA3.1
was obtained from Life Technologies. The reporter plasmids pNF-
κB-Luc (ﬁve NF-κB-resposive elements) and pCRE-Luc (three
copies of CRE-binding sequence) were purchased from Stratagene
and Clonetech, respectively.
Antibodies
The rabbit polyclonal anti-ELL2 (A302-505 A) and the horse-
radish peroxidase-coupled pan-Ubiquitin-antibody (P4D1) were
purchased from Bethyl Laboratories and Santa Cruz Biotechnology,
respectively. Mouse antibodies anti-αTubulin and anti-ßActin
(both Sigma-Aldrich) were used. Mouse antibodies to Tax (1:50)
derived from the hybridoma cell line 168B17-46-34 (Langton et al.,
1988) were obtained from the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH. Lamin B antibody
(M20) was purchased from Santa Cruz Technologies. Horseradish
peroxidase-coupled secondary antibodies were obtained from GE
Healthcare.
Transient transfection
0.5106 293 T cells were seeded 24 h prior to transfection with
GeneJuice reagent (Novagen) or Lipofectamine (Life Technologies)
at a density of 70% according to the manufacturer's protocol.
Increasing amounts of Tax-expression plasmids pcTax (0, 0.5, 1,
1.5, 2.0 mg) or 1.5 mg of Tax-mutants were transfected and replen-
ished with pcDNA3.1 to a total amount of 2 mg. Samples were
taken 48 h post transfection. In one experiment, transfected cells
were incubated in the presence of the proteasome inhibitor
MG-132 (Sigma-Aldrich; 10 mM, 4 h) or the solvent control DMSO.
3106 HTLV-1-transformed MT-2 were transfected with a total
amount of 4 mg of siRNAs using T-cell line nucleofector Kit and
program O-17 of the Nucleofector IIs device (both Lonza). Double-
stranded synthetic siRNAs targeting the coding region of Tax
(Hieshima et al., 2008), or a non-speciﬁc control siRNA (siNon;
GFP-22 siRNA, Qiagen) were used. Cells were lysed for isolation
of protein 24 h post transfection. 1107 Jurkat T-cells were trans-
fected by electroporation (Gene Pulser, Biorad) at 290 V and 1500 μF
with increasing amounts of pcTax (0, 5, 15, 30 mg) replenished with
pcDNA3.1 to 30 μg (Invitrogen). Cells were harvested 48 h after
transfection to isolate RNA and to perform immunoblots.
Microarray analysis
Microarrays have been described previously (Pichler et al.,
2008; Kress et al., 2010), data have been deposited in NCBI's Gene
Expression Omnibus (Edgar et al., 2002) and are accessible at
http://www.ncbi.nlm.nih.gov/geo/ under GEO Series accession
numbers GSE10508 and GSE17718.
RT-PCR and quantitative PCR (qPCR)
Total cellular RNAwas isolated from cell lines or transfected cells
(RNA isolation Kit II, Macherey-Nagel; RNeasy micro Kit; Qiagen)
and reversely transcribed to cDNA (Superscript II) using random
hexamer primers (Life Technologies). 200 ng of cDNAwas subjected
to qPCR using Platinums Quantitative PCR SuperMix-UDG (Life
technologies) and analyzed in an ABI Prism 7500 Sequence Analy-
zer (Applied Biosystems). Primers and FAM (6-carboxyﬂuorescein)/
TAMRA (tetramethylrhodamine)-labeled probes for detection of
ßActin and Tax transcripts have been described before (Kress et
al., 2010; Princler et al., 2003). For quantitation of ELL2 transcripts, a
TaqMan Gene Expression Assay (Hs00831747_s1; Applied Biosys-
tems) was used. Expression levels were computed by interpolation
from standard curves generated from plasmids carrying the respec-
tive target sequences and calculating the mean of triplicate samples.
Relative copy numbers (rcn) were determined by normalizing copy
numbers on those of the housekeeping gene ßActin. Primers
amplifying ßActin and 4-1BB (Pichler et al., 2008) transcripts were
used in RT-PCR (Hironaka et al., 2004). For quantitation of proviral
load, genomic DNA was isolated from PBMC and a total amount of
100 ng DNA was subjected to quantitative PCR. Brieﬂy, the plasmid
pcHTLV-ALB, which carries sequences of the HTLV-1 polymerase
(pol) gene and of the human albumin (alb) gene, was used for
generation of a standard curve. Primers (0.2 mM), probes (0.1 mM),
and PCR conditions for quantitation of pol and alb have been
described (Dehee and Cesaire, 2002). Copy numbers of the HTLV-
1 pol gene were normalized to those of alb.
Western blotting
Cells were lysed using TNE lysis buffer containing 150 mM NaCl,
10 mM Tris pH 7.0, 10 mM EDTA, 1% Triton, 2 mM dithiothreitol
and protease inhibitors (20 μg/ml Leupeptin, 20 μg/ml Aprotinin and
1 mM phenyl-methyl-sulfonyl ﬂuoride) followed by repeated freeze-
and-thaw lysis in liquid nitrogen. Nuclear cytoplasmic fractionation
was performed using Nuclear/Cytoplasmic fractionation Kit (BioVi-
sion Incorporated) according to the manufacturer's protocol. Protein
lysates were centrifuged, denatured and equal amounts of protein
were separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to Nitrocellulose membranes
using standard techniques. Molecular weight markers PageRuler
Prestained Protein Ladder SM0671 (Fermentas) and # 26616 (Thermo
Scientiﬁc) were used. Membranes were probed with the indicated
antibodies. Peroxidase activity was detected by enhanced chemilu-
minescence using a Kodak Image Station 4000 MM PRO camera
(Kodak). At least three independent experiments were performed.
Intensities of speciﬁc bands were quantitated using an Advanced
Image Data Analyzer (AIDA Version 4.22.034, Raytest Isotopenmess-
geräte GmbH, Straubenhardt, Germany).
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Starvation of Tesi cells
For serum starvation experiments, Tesi cells were grown for
48 h in medium containing decreasing concentrations of FCS
(20%, 10%, 5%, 0%). Cells were lysed for RNA and protein isolation.
To assess the proliferation rates of cells, cells were labelled with
Cell Proliferation Dye eFluors 450 (eBioscience), and measured by
ﬂow cytometry using a BD LSR II (Beckton Dickinson). The amount
of cell proliferation was calculated as follows: mean ﬂuorescence
intensity (MFI) of labelled cellsnumber of living cells (as
determined by forward/side scatter).
Co-immunoprecipitation
0.5106 293 T cells were seeded, transfected and lysed as
described above. 5% of the protein lysate was taken as input control,
and the rest was rotated overnight with 2 mg of anti-ELL2, anti-Tax
(Langton et al., 1988), or the respective isotype control antibodies at
4 1C. Then, protein G-coupled magnetic beads (Dynabeads; Life
technologies) were added and rotated again for 1 h at 4 1C. Samples
were washed in TNE lysis buffer and denatured protein lysates were
used for immunoblotting.
Luciferase reporter assays
0.25106 293 T cells were seeded 24 h prior to transfection
with 0.1 mg of the indicated reporter construct and the indicated
expression constructs using GeneJuice. Untransfected or vector-
transfected cells were used as controls. To control speciﬁcity of
pNF-kB-Luc, 0.05 mg of pIκBα-DN was cotransfected. Samples were
replenished with pEF1α to a total amount of 1 mg plasmid DNA.
3106 MT-2 cells were transfected with 0.5 mg of pGL3-U3R
and 2 mg of synthetic siRNAs targeting ELL2 (siELL2; AACCAT-
GAACCCTGCAAATAC; Qiagen) or siNon as described in “Transient
transfection”. Cells were lysed using a lysis buffer containing
100 mM Tris pH 7.8, 1 M DTT, 0.18 mM DCTA, 0.2% Triton X-100,
20% Glycerol and agitated for 30 min at 20 1C. After centrifugation,
Fireﬂy luciferase activities were measured according to the man-
ufacturer's instructions (ORION II luminometer) using assay buffer
(100 mM KPO4, 15 mM MgSO4, 4 mM ATP) and D-luciferin
(0.26 mg/ml; Roche) dissolved in assay buffer. Gaussia luciferase
activities were measured by adding assay buffer (1.1 M NaCl,
2.2 mM Na2EDTA, 0.22 M KPO4 [pH 5.1]) supplemented with
1.43 mM coelenterazine. Relative light units of triplicates were
determined and normalized on protein content. The means of
at least three independently performed experiments 7SE were
calculated.
Statistics
Microsoft Excel 2010 was used for statistical analysis as indicated.
Po 0.05 was considered to be signiﬁcant.
Bioinformatics
MatInspector (Genomatix) was used to search for putative tran-
scription factor binding sites in the ELL2 promoter (Cartharius et al.,
2005). The input sequence comprised of a region from 1142 to
þ154 (þ1 transcription start) of the human ELL2 promoter based on
NT_034772 and NM_012081.
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